GeneDx Holdings (WGS) Gross Margin (2020 - 2026)

GeneDx Holdings has disclosed Gross Margin across 7 years of filings, most recently posting 66.71% for Q1 2026.

• In Q1 2026, Gross Margin fell 42.0% year-over-year to 66.71%; the TTM figure through Mar 2026 stood at 69.56% (up 429.0% YoY), while the FY2025 annual figure was 69.74%, up 610.0% from the prior year.
• Gross Margin retreated to 66.71% in Q1 2026, from 69.65% in the prior quarter.
• Over the last five years, Gross Margin for WGS reached as high as 72.4% in Q3 2025 and fell as low as 81.83% in Q2 2022.
• The 5-year median for Gross Margin is 59.93% (2024), against an average of 40.6%.
• Annual changes were most pronounced in 2022 — Gross Margin sank 7936 bps — and 2023, when it jumped 12034 bps.
• A 5-year view of Gross Margin shows it stood at 26.61% in 2022, then surged by 301 bps to 53.56% in 2023, then gained by 29 bps to 69.22% in 2024, then gained by 1 bps to 69.65% in 2025, then retreated by 4 bps to 66.71% in 2026.
• According to Business Quant data, Gross Margin over the past three periods registered 66.71%, 69.65%, and 72.4% for Q1 2026, Q4 2025, and Q3 2025 respectively.